UFC light heavyweight Khalil Rountree will serve a two-month suspension resulting from a failed drug test.
The UFC’s anti-doping program, Combat Sports Anti-Doping (CSAD), announced on Wednesday via press release.
“CSAD announced today that Khalil Rountree of Las Vegas, NV, has accepted a 2-month sanction for a violation of the UFC Anti-Doping Policy,” the release states.
Rountree (13-5) was set to take on Jamahal Hill at UFC 303 on June 29, but withdrew after revealing on Instagram that he had ingested a banned substance.
“Rountree self-reported to UFC personnel the mistaken use of a dietary supplement that contained DHEA, a prohibited at all times anabolic steroid, as one of it’s several ingredients. Shortly after beginning use of the supplement, a biological sample was collected by Drug Free Sport International (DFSI) from Rountree on May 4th, 2024,” the release continues.
The supplement company has taken full responsibility for sending Rountree the shipment that had DHEA in it calling it a “massive oversight on our part”.
“The evidence reflects that as soon as Rountree realized the mistake, he immediately notified UFC personnel, who immediately passed the information along to CSAD,” says the release.
According to CSAD, his suspension began on May 4. Nevada State Athletic Commission (NSAC) retained jurisdiction over the sample result due to Rountree’s fight having been publicly announced.
NSAC has the option to sanction the UFC light heavyweight further if it sees fit, and will determine that at a future NAC meeting.
